Carvedilol (as phosphate ... Available data in pregnant women are insufficient to determine whether there are drug-associated risks of adverse developmental outcomes. There are risks to the ...

By contrast, a recent randomized, controlled trial shows less bleeding associated with the use of carvedilol compared with EBL. Portal hypertension is a life-threatening complication of cirrhosis ...

[9] Food decreases the absorption of carvedilol, with prolongation of time to peak plasma level but without alteration of the degree of drug absorption. [9] For clinical use, it is recommended ...